Dylan Morris

Insight Partners is a global software investor that partners with high-growth technology, software, and Internet startup companies.

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Raised $82,000,000.00 from Arc Ventures, Innovation Endeavors, Deep Insight, Invus, Novartis Venture Fund, Insight Partners, Deep-Insight, JP Morgan, CRISPR Therapeutics and Delos Capital.

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Raised $153,000,000.00 from NVentures, Catalio Capital Management, Eli Lilly, Gaingels, RA Capital Management, Insight Partners and Cooley.

ImmuneBridge is developing allogeneic immunotherapies for cancer.

Raised $12,000,000.00 from Gaingels, Insight Partners, M Ventures, One Way Ventures, Pioneer Fund, Healthspan Capital and Quiet Capital.

Decoding the language of life with AI

Raised $44,000,000.00 from Insight Partners, AIX Ventures, Jeff Dean, Spark Capital, Air Street Capital and Convergent Ventures.

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

Raised $134,850,000.00 from Wittington Ventures, Radical Ventures, DCVC Bio, DCVC, 8VC, Insight Partners, EPIC Ventures, Mubadala Capital, Necessary Ventures and Altimeter Capital.

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Raised $73,000,000.00 from Yes VC, Jack Abraham, Two Sigma Ventures, SALT Fund, Myelin VC, Plum Alley, Chelsea M.R. Hirschhorn, FJ Labs, Insight Partners and TA Ventures.

Capacity Bio is a therapeutics company that is focused on mitophagy.

Raised $35,000,000.00 from RA Capital Management and Insight Partners.

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

Raised $70,000,000.00 from Emerson Collective, UTokyo Innovation Platform, Pfizer Venture Investments, Astellas Venture Management, Alta Partners, Alexandria Venture Investments, Longwood Fund and Insight Partners.

ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.

Raised $20,000,000.00 from AriMed Advisors, PTX Capital, Innospark Ventures, Viva BioInnovator, Insight Partners, Boehringer Ingelheim Venture Fund and Nor'easter Ventures.